Sunnyvale, CA, United States of America

Angiotrax, Inc.

Calculating rank
USPTO Granted Patents = 15

Forward Citations = 8,283

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Vahid Saadat (15 out of 23 patents)

silverMedal John H Ream (5 out of 14 patents)

bronzeMedal Joseph M Tartaglia (2 out of 33 patents)

4.  Susan Philip (2 out of 2 patents)

5.  Peter K Park (2 out of 6 patents)

6.  Eric W Leopold (2 out of 42 patents)

7.  John A Macoviak (1 out of 52 patents)

8.  James Kermode (1 out of 1 patent)


15 patents:

Company Overview
Angiotrax, Inc. is a biotechnology company based in Sunnyvale, California, specializing in the development of innovative therapies targeting vascular diseases. The organization focuses on leveraging advanced research in molecular biology and pharmacology to create solutions that address critical unmet medical needs in the treatment of conditions related to blood vessel dysfunction. With a commitment to scientific excellence, Angiotrax aims to improve patient outcomes through its cutting-edge therapeutic approaches.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

15 Patents

#230 in Sunnyvale, CA

#5,037 in California

#21,085 in US

#39,991 in the World

Sunnyvale, CA (US)
Sunnyvale, CA, United States of America
Forward Citations = 8,283

8 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Angiotrax, Inc.. Retrieved from https://idiyas.com/company/angiotrax

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…